A panelist discusses how immune thrombocytopenia (ITP) is characterized by isolated low platelet counts due to autoimmune destruction, with classification based on duration (acute, extended, or ...

Dear Dr. Roach: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...

Thrombocytopenia-absent radius syndrome is a rare congenital condition. It causes a low platelet count and the absence of the radius bone in both forearms. Thrombocytopenia occurs when the number of ...

Cerebral venous sinus thrombosis (CVST) with thrombocytopenia is characterized by a blood clot in the brain and a platelet count that’s lower than normal. Prompt medical attention is crucial to lower ...

How Does It Work for ITP? There is no cure for ITP. Its symptoms can vary from person to person, with some people not having any symptoms. Because ITP causes low platelets, the main side effects that ...

Jakafi (ruxolitinib) is a brand-name oral tablet that’s prescribed for myelofibrosis, graft-versus-host disease (GVHD), and other blood conditions in some adults and children. As with other drugs, ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

Abstract and Introduction Review of Normal Platelet Physiology and Megakaryocytopoisis Qualitative Platelet Abnormalities Conclusion References Nitric oxide (NO) is another drug used in the neonatal ...

Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...